CHO jumping: Samsung BioLogics to develop in-house cell line
Samsung BioLogics will begin offering its own CHO cell line for its customers’ development projects from 2019.
Archives for March 20, 2018
Mundipharma goes up against MSD with Herceptin biosimilar in Europe
Mundipharma says it is not concerned at arriving second to market with a trastuzumab biosimilar after inking a deal to commercialise Celltrion’s Herzuma in seven European countries.
LenioBio teams with Dow for tobacco-based expression system
LenioBio will offer cell-free protein expression (CFPE) kits for drug screening through a partnership with DowDuPont, and says it is looking into using the tech for bioprocessing.